- Home
- LOMA vs OMCL Comparison
LOMA vs OMCL Comparison
Compare LOMA & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOMA
- OMCL
- Stock Information
- Founded
- LOMA 1926
- OMCL 1992
- Country
- LOMA Argentina
- OMCL United States
- Employees
- LOMA N/A
- OMCL N/A
- Industry
- LOMA Building Materials
- OMCL Computer Manufacturing
- Sector
- LOMA Industrials
- OMCL Technology
- Exchange
- LOMA Nasdaq
- OMCL Nasdaq
- Market Cap
- LOMA 1.3B
- OMCL 1.5B
- IPO Year
- LOMA 2017
- OMCL 2001
- Fundamental
- Price
- LOMA $10.18
- OMCL $33.62
- Analyst Decision
- LOMA Strong Buy
- OMCL Buy
- Analyst Count
- LOMA 2
- OMCL 7
- Target Price
- LOMA $15.00
- OMCL $46.71
- AVG Volume (30 Days)
- LOMA 491.3K
- OMCL 599.4K
- Earning Date
- LOMA 08-07-2025
- OMCL 07-31-2025
- Dividend Yield
- LOMA N/A
- OMCL N/A
- EPS Growth
- LOMA N/A
- OMCL N/A
- EPS
- LOMA 0.37
- OMCL 0.49
- Revenue
- LOMA $559,741,122.00
- OMCL $1,149,529,000.00
- Revenue This Year
- LOMA $22.92
- OMCL $3.84
- Revenue Next Year
- LOMA $25.84
- OMCL $3.98
- P/E Ratio
- LOMA $27.67
- OMCL $67.71
- Revenue Growth
- LOMA N/A
- OMCL 6.39
- 52 Week Low
- LOMA $6.76
- OMCL $22.66
- 52 Week High
- LOMA $14.17
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- LOMA 36.10
- OMCL 74.17
- Support Level
- LOMA $11.00
- OMCL $31.34
- Resistance Level
- LOMA $10.87
- OMCL $32.40
- Average True Range (ATR)
- LOMA 0.50
- OMCL 0.85
- MACD
- LOMA -0.16
- OMCL 0.17
- Stochastic Oscillator
- LOMA 4.37
- OMCL 97.53
About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.